VERU Veru Inc

Price (delayed)

$4.16

Market cap

$66.77M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.78

Enterprise value

$42.01M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 13

Veru Inc. is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer. The Veru prostate cancer pipeline includes VERU-111, ...

Highlights
The EPS has soared by 68% YoY and by 35% from the previous quarter
The net income has soared by 62% YoY and by 27% from the previous quarter
The equity has soared by 65% YoY but it has contracted by 6% from the previous quarter

Key stats

What are the main financial stats of VERU

VERU stock price

How has the Veru stock price performed over time
Intraday
84.89%
1 week
79.31%
1 month
84.89%
1 year
-36.29%
YTD
94.39%
QTD
88.24%

Financial performance

How have Veru's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$19.02M
Net income
-$13.95M
Gross margin
N/A
Net margin
N/A
The net income has soared by 62% YoY and by 27% from the previous quarter
The operating income has surged by 50% year-on-year and by 4.5% since the previous quarter

Price vs fundamentals

How does VERU's price correlate with its fundamentals

Growth

What is Veru's growth rate over time

Valuation

What is Veru stock price valuation
P/E
N/A
P/B
1.92
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 68% YoY and by 35% from the previous quarter
The P/B is 75% below the 5-year quarterly average of 4.2 and 60% below the last 4 quarters average of 2.6
The equity has soared by 65% YoY but it has contracted by 6% from the previous quarter

Efficiency

How efficient is Veru business performance
Veru's ROE has soared by 57% YoY and by 36% from the previous quarter
The ROA has grown by 49% YoY and by 32% from the previous quarter
The return on invested capital has grown by 40% since the previous quarter but it has declined by 35% year-on-year

Dividends

What is VERU's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VERU.

Financial health

How did Veru financials performed over time
Veru's current ratio has soared by 63% YoY and by 20% from the previous quarter
The quick ratio has soared by 60% YoY and by 15% from the previous quarter
VERU's debt is 92% smaller than its equity
The equity has soared by 65% YoY but it has contracted by 6% from the previous quarter
The debt to equity has dropped by 50% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.